Conmed Corp (CNMD) Stock Price & Analysis
Conmed Corp (CNMD) fell 0.20% to USD 49.32 as of September 8, 2026 at 11:15 UTC, according to Nexqual real-time market data.
CNMD last closed at USD 49.32; the session ranged USD 48.61–49.52 on volume of 281,280 shares. Market capitalization is —, with a 52-week range of USD 31.44–54.22 (NYQ). Source: Nexqual, September 8, 2026 at 11:15 UTC.
Key Statistics (as of September 8, 2026 at 11:15 UTC)
| Price | USD 49.32 |
|---|---|
| Change | ▼ 0.20% (down) |
| Previous Close | USD 49.32 |
| Open | USD 49.32 |
| Day Range | USD 48.61 – 49.52 |
| 52-Week Range | USD 31.44 – 54.22 |
| Volume | 281,280 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (CNMD)
Nexqual's technical model rates CNMD "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 11:15 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.23 (neutral) |
| vs SMA50 | Above (USD 45.01) |
| MACD | 1.07 (positive) |
From Conmed Corp's Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- For example, our manufacturing processes and facilities, and those of third parties we contract with to provide regulated products and services, are subject to the FDA's Quality System Regulation ("QSR") and similar laws and regulations governing quality in other jurisdictions, and many of our products also are subject to industry-defined standards.
- We also pursue organic growth by focusing on our differentiated products.
- These products allow us to reach more surgeons and physicians and in turn also introduce other products in our portfolios. • Conduct Product Portfolio Review and Optimization.   We continuously review our product portfolio.
- The breadth of our product lines in our key product areas enables us to meet a wide range of customer requirements and preferences.  This has enhanced our ability to market our products to surgeons, hospitals, surgery centers, group purchasing organizations ("GPOs"), integrated delivery networks ("IDNs") and other customers, particularly as institutions seek to reduce costs and minimize the number of suppliers.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OFIX | Orthofix Medical Inc. | USD 9.29 | ▼ 0.96% |
| ICUI | ICU Medical, Inc. | USD 167.58 | ▼ 1.34% |
| IART | Integra LifeSciences Holdings C | USD 16.72 | ▼ 0.54% |
| MMSI | Merit Medical Systems, Inc. | USD 89.6 | ▼ 0.59% |
| HAE | Haemonetics Corporation | USD 102.92 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 11:15 UTC. This page is informational and not investment advice.